These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18501259)

  • 21. Pharmacology of visceral pain: central factors.
    Aziz Q; Botha C; Willert R
    Dig Dis; 2009; 27 Suppl 1():31-41. PubMed ID: 20203495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Irritable bowel syndrome: a model of the brain-gut interactions.
    Mulak A; Bonaz B
    Med Sci Monit; 2004 Apr; 10(4):RA55-62. PubMed ID: 15260348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New insights into the pathogenesis and pathophysiology of irritable bowel syndrome.
    Ohman L; Simrén M
    Dig Liver Dis; 2007 Mar; 39(3):201-15. PubMed ID: 17267314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Visceral sensitivity disturbances in the pathogenesis of functional gastrointestinal disorders].
    Mazur M; Furgała A; Thor PJ
    Folia Med Cracov; 2004; 45(1-2):33-49. PubMed ID: 16276824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in intestinal motility, visceral sensitivity and minor mucosal inflammation after fasting therapy in a patient with irritable bowel syndrome.
    Kano M; Fukudo S; Kanazawa M; Endo Y; Narita H; Tamura D; Hongo M
    J Gastroenterol Hepatol; 2006 Jun; 21(6):1078-9. PubMed ID: 16725003
    [No Abstract]   [Full Text] [Related]  

  • 26. Activating endogenous visceral pain modulation: a comparison of heterotopic stimulation methods in healthy controls.
    Wilder-Smith CH; Song G; Yeoh KG; Ho KY
    Eur J Pain; 2009 Sep; 13(8):836-42. PubMed ID: 19004650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of chili on postprandial gastrointestinal symptoms in diarrhoea predominant irritable bowel syndrome: evidence for capsaicin-sensitive visceral nociception hypersensitivity.
    Gonlachanvit S; Mahayosnond A; Kullavanijaya P
    Neurogastroenterol Motil; 2009 Jan; 21(1):23-32. PubMed ID: 18647268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Individual reactivity to the open-field predicts the expression of cardiovascular and behavioural sensitisation to novel stress.
    Geerse GJ; van Gurp LC; Wiegant VM; Stam R
    Behav Brain Res; 2006 Nov; 175(1):9-17. PubMed ID: 16926056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dynamics of clinical symptoms and indices of visceral sensitivity in patients with the irritated bowels syndrome treated with meteospasmyl].
    Makarchuk PA; Golovenko OV; Mikhaĭlova TL; Podmarenkova LF
    Eksp Klin Gastroenterol; 2005; (1):25-9. PubMed ID: 15991849
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of depressive symptoms on visceral sensitivity among patients with different subtypes of irritable bowel syndrome.
    de Medeiros MT; Carvalho AF; de Oliveira Lima JW; Dos Santos AA; de Oliveira RB; Nobre E Souza MA
    J Nerv Ment Dis; 2008 Sep; 196(9):711-4. PubMed ID: 18791434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visceral hypersensitivity: fact or fiction.
    Aziz Q
    Gastroenterology; 2006 Aug; 131(2):661-4. PubMed ID: 16890617
    [No Abstract]   [Full Text] [Related]  

  • 32. The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome.
    Grover M; Herfarth H; Drossman DA
    Clin Gastroenterol Hepatol; 2009 Jan; 7(1):48-53. PubMed ID: 18848909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epidemiology and clinical phenomenology of visceral pain].
    Gschossmann JM; Holtmann G; Mayer EA
    Schmerz; 2002 Dec; 16(6):447-51. PubMed ID: 12474030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hypnosis in gastroenterology].
    Häuser W
    Z Gastroenterol; 2003 May; 41(5):405-12. PubMed ID: 12772053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal and anorectal motility and functional disorders.
    Keller J; Layer P
    Best Pract Res Clin Gastroenterol; 2009; 23(3):407-23. PubMed ID: 19505668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered protease signalling in the gut: a novel pathophysiological factor in irritable bowel syndrome.
    Róka R; Wittmann T; Bueno L
    Neurogastroenterol Motil; 2008 Aug; 20(8):853-6. PubMed ID: 18710475
    [No Abstract]   [Full Text] [Related]  

  • 37. [Dynamics of indices of visceral sensitivity in patients with irritable bowel syndrome treated with spasmolytics].
    Makarchuk PA
    Eksp Klin Gastroenterol; 2007; (6):126-9. PubMed ID: 18418922
    [No Abstract]   [Full Text] [Related]  

  • 38. New insights into the pathophysiology of IBS: intestinal microflora, gas production and gut motility.
    Gasbarrini A; Lauritano EC; Garcovich M; Sparano L; Gasbarrini G
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():111-7. PubMed ID: 18924450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review article: the psychoneuroimmunology of irritable bowel syndrome--an exploration of interactions between psychological, neurological and immunological observations.
    Arebi N; Gurmany S; Bullas D; Hobson A; Stagg A; Kamm M
    Aliment Pharmacol Ther; 2008 Oct; 28(7):830-40. PubMed ID: 18637004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postinfectious irritable bowel syndrome.
    Barbara G; Cremon C; Pallotti F; De Giorgio R; Stanghellini V; Corinaldesi R
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S95-7. PubMed ID: 19300138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.